Robenacoxib
Appearance
(Redirected from C16H13F4NO2)
Clinical data | |
---|---|
Trade names | Onsior |
ATCvet code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.210.035 |
Chemical and physical data | |
Formula | C16H13F4NO2 |
Molar mass | 327.279 g·mol−1 |
3D model (JSmol) | |
| |
|
Robenacoxib, sold under the brand name Onsior, is a nonsteroidal anti-inflammatory drug (NSAID) used in veterinary medicine for the relief of pain and inflammation in cats and dogs.[4][5] It is a COX-2 inhibitor (coxib).
References
[edit]- ^ "Onsior- robenacoxib injection". DailyMed. 19 November 2020. Retrieved 29 June 2024.
- ^ "Onsior- robenacoxib tablet". DailyMed. 9 November 2023. Retrieved 29 June 2024.
- ^ "Onsior EPAR". European Medicines Agency. 13 January 2010. Retrieved 29 June 2024.
- ^ Gaynor JS, Muir WM (2014). "Robenacoxib". Handbook of Veterinary Pain Management (3rd, revised ed.). Elsevier Health Sciences. ISBN 9780323222143.
- ^ Clark-Price S (2014). "Nonsteroidal anti-inflammatory drugs and corticosteroids: Robenacoxib". In Egger CM, Love L, Doherty T (eds.). Pain management in veterinary practice. Ames, Iowa: Wiley-Blackwell. ISBN 9781118761601.